FASEB J. FASEB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
fj.08-126763v1
23/9/2917    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eble, J. A.
Right arrow Articles by Stetefeld, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eble, J. A.
Right arrow Articles by Stetefeld, J.
Published online before print April 15, 2009 as doi: 10.1096/fj.08-126763.

The {alpha}2{beta}1 integrin-specific antagonist rhodocetin is a cruciform, heterotetrameric molecule

Johannes A. Eble, Stephan Niland, Thilo Bracht, Michael Mormann, Jasna Peter-Katalinic, Gottfried Pohlentz, and Jörg Stetefeld

E-mail contact: eble@med.uni-frankfurt.de

The integrin {alpha}2{beta}1 plays an important role in various pathophysiological processes, such as thrombosis, wound healing, inflammation, and metastasis. Rhodocetin, a constituent of the venom of the hemorrhagic Malayan pit viper (Calloselasma rhodostoma), is a specific {alpha}2{beta}1 integrin antagonist. To understand its molecular mode of action, its structure was studied by crystallography. Its quaternary structure in solution was also analyzed biochemically. Two novel subunits of rhodocetin were sequenced by mass spectrometry. Their integrin binding was measured by protein interaction ELISAs. Rhodocetin is a C-type lectin-like protein (CLP) consisting of four homologous, yet distinct, subunits, {alpha}, {beta}, {gamma}, and {delta}, the latter two of which have been unknown to date. With their CLP folds and loop-swapping motifs, the subunits {alpha}, {beta} and {gamma}, {delta} form two heterodimeric pairs. Uniquely, they arrange orthogonally and shape a cruciform molecule. Bearing a single unpaired cysteine residue, rhodocetin can only form covalent supramolecular complexes with a maximum aggregation number of 2, unlike many heterodimeric CLPs. Being the first heterotetrameric CLP to be crystallized, rhodocetin provides not only the prototypic molecular structure for heterotetrameric CLPs, but also a lead structure for pharmaceutical {alpha}2{beta}1 integrin antagonists.—Eble, J. A., Niland, S., Bracht, T., Mormann, M., Peter-Katalinic, J., Pohlentz, G., Stetefeld, J. The {alpha}2{beta}1 integrin-specific antagonist rhodocetin is a cruciform, heterotetrameric molecule.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2009 by The Federation of American Societies for Experimental Biology.